Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives $22.14 Average Price Target from Analysts
Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Get Free Report) have been given an average rating of “Buy” by the nine research firms that are presently covering the stock, MarketBeat reports. Eight analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12 […]
21 Sep 10:37 · The Markets Daily